报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 82.92% | -2.77% | 0.11% | 12/54 | 69.26% | 我武生物 | 95.26% | 行业排名> |
2024-06-30 | 82.82% | -2.67% | -0.09% | 13/54 | 68.54% | 西藏药业 | 95.7% | 行业排名> |
2024-03-31 | 82.9% | -1.83% | -0.9% | 14/54 | 69.17% | 康华生物 | 95.85% | 行业排名> |
2023-12-31 | 83.65% | -3.98% | -1.91% | 15/54 | 68.33% | 我武生物 | 95.26% | 行业排名> |
2023-09-30 | 85.28% | -3.83% | 0.21% | 14/54 | 68.07% | 我武生物 | 95.4% | 行业排名> |
2023-06-30 | 85.09% | -4.62% | 0.78% | 15/54 | 63.32% | 华兰疫苗 | 101.02% | 行业排名> |
2023-03-31 | 84.44% | -5.77% | -3.07% | 19/54 | 69.48% | 华兰疫苗 | 100.22% | 行业排名> |
2022-12-31 | 87.11% | -3.05% | -1.76% | 13/54 | 68.27% | 我武生物 | 95.39% | 行业排名> |
2022-09-30 | 88.67% | -1.38% | -0.61% | 11/54 | 71.28% | 我武生物 | 95.63% | 行业排名> |
2022-06-30 | 89.22% | -0.15% | -0.44% | 9/54 | 69.18% | 我武生物 | 95.75% | 行业排名> |
2022-03-31 | 89.61% | 6.05% | -0.26% | 11/54 | 71.63% | 华兰疫苗 | 98.39% | 行业排名> |
2021-12-31 | 89.85% | 4.17% | -0.07% | 9/54 | 72.33% | 百奥泰 | 95.74% | 行业排名> |
2021-09-30 | 89.91% | 4.86% | 0.62% | 10/54 | 73.87% | 我武生物 | 95.89% | 行业排名> |
2021-06-30 | 89.35% | 4.76% | 3.6% | 10/54 | 73.72% | 百奥泰 | 96.33% | 行业排名> |
2020-12-31 | 86.25% | 0.66% | 1.12% | 19/54 | 71.61% | 义翘神州 | 96.83% | 行业排名> |
2020-06-30 | 85.3% | -0.15% | 0.95% | 18/54 | 88.2% | 义翘神州 | 96.88% | 行业排名> |
2020-03-31 | 84.5% | -0.65% | -1.39% | 13/54 | 70.26% | 义翘神州 | 96.56% | 行业排名> |
2019-12-31 | 85.69% | 0.62% | -0.07% | 18/54 | 72.44% | 华兰疫苗 | 707.43% | 行业排名> |
2019-09-30 | 85.75% | 2% | 0.38% | 11/54 | 70.09% | 我武生物 | 95.6% | 行业排名> |
2019-06-30 | 85.42% | 2% | 0.44% | 11/54 | 69.35% | 我武生物 | 96.43% | 行业排名> |
2019-03-31 | 85.05% | 2% | -0.13% | 8/54 | 69.07% | 我武生物 | 96.51% | 行业排名> |
2018-12-31 | 85.16% | 2% | 2% | 15/54 | 71.54% | 我武生物 | 96.46% | 行业排名> |